Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-04 @ 9:01 AM
Study NCT ID:
NCT02017457
Status:
COMPLETED
Last Update Posted:
2019-12-10
First Post:
2013-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
Sponsor:
Carlos Graux, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
None
Primary Completion Date:
2019-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-16
First Submit QC Date:
None
Study First Post Date:
2013-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-06
Last Update Post Date:
2019-12-10
Last Update Post Date Type:
ACTUAL